Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefan Felder

Showing results (1-10 of 38) with videos related to

Pageof 4
Sort By:
Journal of Health Economics|January 6, 2020
The treatment decision under uncertainty: The effects of health, wealth and the probability of deathStefan Felder
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|March 11, 2005
Drug price regulation under consumer moral hazard. Two-part tariffs, uniform price or third-degree price discrimination?Stefan Felder
International Journal of Health Care Finance and Economics|December 25, 2008
The variance of length of stay and the optimal DRG outlier paymentsStefan Felder
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|December 2, 2021
Decision thresholds with genetic testingStefan Felder
Journal of Health Economics|August 5, 2008
To wait or to pay for medical treatment? Restraining ex-post moral hazard in health insuranceStefan Felder
Pharmacoeconomics|February 8, 2013
Disease management programmes in Germany: a fundamental faultStefan Felder
International Journal of Environmental Research and Public Health|June 21, 2013
Can decision biases improve insurance outcomes? An experiment on status quo bias in health insurance choiceMiriam Krieger, Stefan Felder
Expert Review of Pharmacoeconomics & Outcomes Research|June 10, 2010
Health status and the cost of intensive care unit treatmentWalter Ried, Stefan Felder
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|December 28, 2017
Threshold analysis in the presence of both the diagnostic and the therapeutic riskStefan Felder, Thomas Mayrhofer
Statistics in Medicine|October 17, 2025
Determining the Optimal Sequence of Multiple TestsLucas Böttcher, Stefan Felder
Pageof 4

Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
Journal of Health Economics|January 6, 2020
The treatment decision under uncertainty: The effects of health, wealth and the probability of deathStefan Felder
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|March 11, 2005
Drug price regulation under consumer moral hazard. Two-part tariffs, uniform price or third-degree price discrimination?Stefan Felder
International Journal of Health Care Finance and Economics|December 25, 2008
The variance of length of stay and the optimal DRG outlier paymentsStefan Felder
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|December 2, 2021
Decision thresholds with genetic testingStefan Felder
Journal of Health Economics|August 5, 2008
To wait or to pay for medical treatment? Restraining ex-post moral hazard in health insuranceStefan Felder
Pharmacoeconomics|February 8, 2013
Disease management programmes in Germany: a fundamental faultStefan Felder
International Journal of Environmental Research and Public Health|June 21, 2013
Can decision biases improve insurance outcomes? An experiment on status quo bias in health insurance choiceMiriam Krieger, Stefan Felder
Expert Review of Pharmacoeconomics & Outcomes Research|June 10, 2010
Health status and the cost of intensive care unit treatmentWalter Ried, Stefan Felder
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|December 28, 2017
Threshold analysis in the presence of both the diagnostic and the therapeutic riskStefan Felder, Thomas Mayrhofer
Statistics in Medicine|October 17, 2025
Determining the Optimal Sequence of Multiple TestsLucas Böttcher, Stefan Felder
Pageof 4